Overview

Effects Of GW572016 In Combination With Docetaxel (TAXOTERE)

Status:
Completed
Trial end date:
2006-01-21
Target enrollment:
Participant gender:
Summary
This is a safety and tolerability study of GW572016 given with docetaxel (TAXOTERE).
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Docetaxel
Lapatinib